Pershing Square Capital Management, L.P.Pershing Square Capital Management, L.P.

Institutional investor · Portfolio as of Q4 2020

SEC EDGAR SourceSEC Filings

Top Holdings7 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

LOWE'S COS INC

12.4M$2B19.9%$80.34+79.44%
9 qtrssince 2018-Q4
Decreased
0

CHIPOTLE MEXICAN GRILL INC

1.2M$1.6B16.1%$8.48+224.06%
9 qtrssince 2018-Q4
Unchanged
0

RESTAURANT BRANDS INTERN

25M$1.5B15.3%$42.76+21.62%
9 qtrssince 2018-Q4
Decreased
0

HILTON WORLDWIDE HLDGS

13.4M$1.5B14.8%$69.13+57.41%
9 qtrssince 2018-Q4
Decreased
0

AGILENT TECHNOLOGIES INC

12.2M$1.4B14.5%$70.86+59.86%
6 qtrssince 2019-Q3
Decreased
0

STARBUCKS CORP

10.1M$1.1B10.8%$55.48+94.53%
9 qtrssince 2018-Q4
Decreased
0

HOWARD HUGHES CORPORATION

10.9M$861.8M8.6%
9 qtrssince 2018-Q4
Unchanged
0
$10B
AUM
7
Positions
Q4 2020
Filing
Rating · 1.0
Quarterly Portfolio Change
-3%Q3'19$6.5B+1%Q4'19$6.6B+0%Q1'20$6.6B+18%Q2'20$7.8B+14%Q3'20$8.8B+13%Q4'20$10B
Activity profile
$ moved · Q4'20
New0%Increased0%Decreased100%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.9 years
<1Q0%1-4Q0%1-2Y14%2Y+86%

Pershing Square Capital Management, L.P. manages $10B across 7 positions as of Q4 2020. Top holdings: LOW (19.9%), CMG (16.1%), QSR (15.3%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1/5.0.

Q4 2020 Summary

Trimmed 5. No standout high-conviction moves this quarter. Portfolio: $10.0B across 7 positions.

Top holdings by portfolio weight

Total AUM$10B
LOW19.88%
CMG16.10%
QSR15.30%
HLT14.85%
A14.49%
SBUX10.77%
HHC8.62%

Portfolio allocation by GICS sector

Sectors3
Consumer Cyclical76.89%
Healthcare14.49%
Unknown8.62%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Consumer Cyclical, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Weak(1.0 / 5.0)
Track RecordNo data
Conviction46
Concentration0
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
AMZNAMZNAMAZON.COM INC
Q4 2025 Q1 2026+5.6M shares+$1.1B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used